Arcus Biosciences (RCUS) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$831.0 million.
- Arcus Biosciences' Enterprise Value rose 2369.15% to -$831.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$831.0 million, marking a year-over-year increase of 2369.15%. This contributed to the annual value of -$978.0 million for FY2024, which is 2885.38% down from last year.
- Arcus Biosciences' Enterprise Value amounted to -$831.0 million in Q3 2025, which was up 2369.15% from -$911.0 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Enterprise Value ranged from a high of -$499.0 million in Q4 2021 and a low of -$1.2 billion during Q1 2022
- Moreover, its 5-year median value for Enterprise Value was -$954.0 million (2023), whereas its average is -$906.8 million.
- Examining YoY changes over the last 5 years, Arcus Biosciences' Enterprise Value showed a top increase of 3294.73% in 2021 and a maximum decrease of 42381.51% in 2021.
- Quarter analysis of 5 years shows Arcus Biosciences' Enterprise Value stood at -$499.0 million in 2021, then tumbled by 102.2% to -$1.0 billion in 2022, then rose by 24.78% to -$759.0 million in 2023, then dropped by 28.85% to -$978.0 million in 2024, then grew by 15.03% to -$831.0 million in 2025.
- Its Enterprise Value was -$831.0 million in Q3 2025, compared to -$911.0 million in Q2 2025 and -$997.0 million in Q1 2025.